In neonatal cholestasis, if the serum gamaglutamyl–transpeptidase (gamma GTP) is more than 600 IU/L the most likely diagnosis is –
**Core Concept**
In neonatal cholestasis, elevated serum gamma-glutamyltransferase (GGT) levels, particularly above 600 IU/L, suggest an extrahepatic cause of obstruction rather than a hepatocellular or intrahepatic cause. This distinction is crucial for guiding further diagnostic and therapeutic management.
**Why the Correct Answer is Right**
Gamma-glutamyltransferase (GGT) is a liver enzyme that is elevated in conditions involving bile duct obstruction or damage to the bile ducts. In neonatal cholestasis, when GGT levels exceed 600 IU/L, it indicates an extrahepatic cause, such as biliary atresia or choledochal cysts. These conditions involve obstruction or blockage of the bile ducts outside the liver, leading to significant elevation of GGT levels. In contrast, intrahepatic causes of cholestasis, such as congenital hepatitis or alpha-1 antitrypsin deficiency, are typically associated with lower GGT levels.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not applicable as the question stem does not provide any information about this choice.
**Option B:** This option is incorrect because it does not directly relate to the clinical significance of elevated GGT levels in neonatal cholestasis.
**Option C:** This option is incorrect because it does not address the specific scenario of elevated GGT levels in neonatal cholestasis.
**Clinical Pearl / High-Yield Fact**
In neonatal cholestasis, a high GGT level above 600 IU/L is a red flag for extrahepatic bile duct obstruction, prompting further investigation with imaging studies like ultrasound, CT scan, or MRCP to identify the underlying cause.
**Correct Answer: C. Biliary atresia**